Prediction of precipitation-induced phlebitis: A statistical validation of an in vitro model

Journal of Pharmaceutical Sciences

Volumn 92, Issue 8, 2003, Pages 1574-1581

  Johnson, Jennifer L H ^a   He, Yan ^a   Yalkowsky, Samuel H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

In vitro model; Intravenous; Phlebitis; Precipitation; Validation

Indexed keywords

ACICLOVIR; ADRENALIN; AMIODARONE; ATROPINE; BRETYLIUM TOSYLATE; CIPROFLOXACIN; DIAZEPAM; DILTIAZEM; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLUCOSE; LIDOCAINE; NAFCILLIN; OFLOXACIN; PHENYTOIN; PHYTOMENADIONE; SODIUM CHLORIDE; WATER;

ACCURACY; ARTICLE; DRUG SCREENING; INJECTION; LOGISTIC REGRESSION ANALYSIS; MODEL; PHLEBITIS; PRECIPITATION; VALIDATION PROCESS;

EID: 0043212022     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10396     Document Type: Article

References (24)

1. Trissel LA. 2001. Handbook on injectable drugs, 11th ed. Bethesda, MD: American Society of Health System Pharmacists, p XIV.
2. Stedman's medical dictionary. 1999. Baltimore: Lippincott Williams & Wilkins.
3. Turco SJ, King RE. 1979. Sterile dosage forms, 2nd ed. Philadelphia: Lea & Febiger, p 407.
4. Avis KE, Lachman L, Lieberman HA. 1986. Pharmaceutical dosage forms: Parenteral medications, Vol. 2. Portland, OR: Book News, Inc., pp 217-222.
5. Wu CC, Chen WJ, Cheng J, Hsieh YY, Lien WP. 1991. Local dermal hypersensitivity from dobutamine hydrochloride (Dobutrex Solution) injection. Chest 99(6):1547-1548.
6. Li P, Vishnuvajjala R, Tabibi SE, Yalkowsky SH. 1998. Evaluation of in vitro precipitation methods. J Pharm Sci 87:196-199.
7. Turco SJ. 1987. Infusion phlebitis: A review of the literature. Parenterals 5:1-8.
8. Ward GH, Yalkowsky SH. 1993. Studies in phlebitis. VI. Dilution-induced precipitation of amiodarone HCL. J Parenter Sci Technol 47(4):161-165.
9. Yalkowsky SH, Krzyzaniak JF, Ward GH. 1998. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci 87:787-796.
10. Yalkowsky SH, Valvani SC, Johnson BJ. 1983. In vitro method for detecting precipitation of parenteral formulations after injection. J Pharm Sci 72:1014-1017.
11. Vorbach H, Weigel G, Robibaro B, Reiter M, Hlousek M, Armbruster C, Griesmacher A, Georgopuolos A, Graninger W. 1998. Endothelial purine content: An alternative model for testing antibiotic solutions for intravenous use. Adv Exp Med Biol 431:827-831.
12. Yalkowsky SH, Valvani SC. 1977. Precipitation of solubilized drugs due to injection or dilution. Drug Intell Clin Pharm 11:417-419.
13. Davio SR, McShane MM, Kakuk TJ, Zaya RM, Cole SL. 1991. Precipitation of the rennin inhibitor ditekiren upon IV infusion; in vitro studies and their relationship to in vivo precipitation in the cynomolgus monkey. Pharm Res 8:80-83.
14. Greenfield JC, Loux SJ, Sood VK, Jenkins KM, Davio SR. 1991. In vitro evaluation of the plasma and blood compatibility of a parenteral formulation for ditekiren, a novel renin inhibitor pseudopeptide. Pharm Res 8:475-479.
15. Rowland M, Tozer TN. 1995. Clinical pharmacokinetics concepts and applications, 3rd ed. Baltimore: Lippincott Williams & Wilkins, p 138.
16. Abbott Laboratories NDA no. 13-025/S-035 submission. Internet address: www.fda.gov/cder/ogd/rld/13025S35.pdf.
17. Surakitbanharn Y, Simamora P, Ward GH, Yalkowsky SH. 1994. Precipitation of pH solubilized phenytoin. Int J Pharm 109:27-33.
18. StataQuest 4 statistical software, Windows 95 edition. Stata Corporation, 702 University Drive East, College Station, TX 77840.
19. MedCalc statistical software, Version 6.16. MedCalc software, Broekstraat 52, 9030 Mariakerke, Belgium.
20. Kay B, Rolly G. 1977. The effect of a change of formulation on the incidence of pain after intravenous injection. Acta Anaesthesiol Belg 4:317-322.
21. Myrdal PB, Simamora P, Surakitbanharn Y, Yalkowsky SH. 1995. Studies in phlebitis. VII. In vitro and in vivo evaluation of pH-solubilized levemopamil. J Pharm Sci 84:849-852.
22. Sweetana S, Akers MJ. 1996. Solubility principles and practices for parenteral drug dosage form development. PDA J Pharm Sci Technol 50:330-342.
23. Arndt KA. 1988. Adverse reactions to acyclovir: Topical, oral, and intravenous. J Am Acad Dermatol 18:188-190.
24. Pagano M, Gauvreau K. 1993. Principles of biostatistics. Belmont, CA: Duxbury Press, pp 473-475.